Edgestream Partners’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$505K	Sell	15,275 -2,941	-16%	-$97.2K	0.01%	730
2025 Q1	$732K	Buy	+18,216	New	+$732K	0.02%	652
2024 Q3	–	Sell	-15,835	Closed	-$858K	–	887
2024 Q2	$858K	Buy	+15,835	New	+$858K	0.04%	556